Renasant Bank
ABBV icon

Renasant Bank’s AbbVie ABBV Stock Holding History

Renasant Bank’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.53M Sell
5,858
-474
-7% -$122K 1.03% 29
2026
Q2 		$1.59M Buy
6,332
+1,377
+28% +$296K 1.02% 29
2026
Q1 		$1.08M Buy
4,955
+2,914
+143% +$646K 0.76% 34
2025
Q4 		$466K Sell
2,041
-157
-7% -$35.8K 0.32% 88
2025
Q3 		$509K Sell
2,198
-24
-1% -$4.89K 0.32% 88
2025
Q2 		$412K Sell
2,222
-3,187
-59% -$592K 0.28% 98
2025
Q1 		$1.13M Sell
5,409
-1,919
-26% -$373K 0.75% 37
2024
Q4 		$1.3M Buy
7,328
+210
+3% +$38.6K 0.84% 34
2024
Q3 		$1.41M Sell
7,118
-658
-8% -$123K 0.92% 30
2024
Q2 		$1.33M Sell
7,776
-1,468
-16% -$243K 0.92% 36
2024
Q1 		$1.68M Sell
9,244
-906
-9% -$156K 1.2% 15
2023
Q4 		$1.57M Buy
10,150
+1,066
+12% +$155K 1.25% 12
2023
Q3 		$1.35M Buy
9,084
+1,014
+13% +$149K 1.14% 14
2023
Q2 		$1.09M Sell
8,070
-1,498
-16% -$220K 0.89% 29
2023
Q1 		$1.52M Sell
9,568
-495
-5% -$75.7K 1.18% 15
2022
Q4 		$1.63M Sell
10,063
-489
-5% -$75K 1.23% 13
2022
Q3 		$1.42M Buy
10,552
+1,435
+16% +$206K 1.25% 16
2022
Q2 		$1.4M Buy
9,117
+1,337
+17% +$204K 1.14% 17
2022
Q1 		$1.26M Buy
7,780
+1,761
+29% +$256K 0.85% 29
2021
Q4 		$815K Buy
6,019
+1,310
+28% +$155K 0.55% 47
2021
Q3 		$508K Sell
4,709
-411
-8% -$47K 0.4% 81
2021
Q2 		$576K Buy
5,120
+40
+0.8% +$4.5K 0.44% 74
2021
Q1 		$549K Sell
5,080
-729
-13% -$78K 0.44% 69
2020
Q4 		$622K Buy
+5,809
New +$558K 0.51% 55

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Renasant Bank's ABBV Position: Q3 2026 in Review

Renasant Bank reduced its AbbVie (ABBV) stake by 7.5% in Q3 2026, selling an estimated $122K and leaving 5,858 shares worth $1.53M. The position accounts for 1.03% of the portfolio, ranked #29.

Renasant Bank first reported a position in ABBV in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.68M in Q1 2024. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Renasant Bank held 5,858 shares of AbbVie worth $1.53M as of Q3 2026.
  • Renasant Bank sold 474 AbbVie shares in Q3 2026, an estimated $122K.
  • AbbVie made up 1.03% of Renasant Bank's portfolio in Q3 2026, its #29 holding.
  • Renasant Bank first reported a position in AbbVie in Q4 2020 and has held it in 24 quarters since.
  • Renasant Bank's AbbVie position peaked at $1.68M in Q1 2024.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Renasant Bank's 13F filing for Q3 2026, filed 5 Nov 2026.